Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function

Journal of Cardiology

Volumn 61, Issue 5, 2013, Pages 359-364

  Çetin, Mustafa ^a   Kocaman, Sinan Altan ^a   Durakoĝlugil, Murtaza Emre ^b   Erdoĝan, Turan ^b   Ergül, Elif ^a   Dogan, Sitki ^a   Çanga, Aytun ^a  

^a Rize Education and Research Hospital   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Diastolic dysfunction; Epicardial adipose tissue; Hypertension; Left atrial dilatation; Obesity

Indexed keywords

ADIPOSE TISSUE; ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CROSS-SECTIONAL STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; EPICARDIAL ADIPOSE TISSUE; ESSENTIAL HYPERTENSION; FEMALE; FRAMINGHAM RISK SCORE; HEART ATRIUM ENLARGEMENT; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY;

ADIPOSE TISSUE; ADULT; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PERICARDIUM; REGRESSION ANALYSIS;

EID: 84877616926     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.12.015     Document Type: Article

References (43)

1. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., Waggoner A.D., Flachskampf F.A., Pellikka P.A., Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22:107-133.
2. Ahmed A., Rich M.W., Sanders P.W., Perry G.J., Bakris G.L., Zile M.R., Love T.E., Aban I.B., Shlipak M.G. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007, 99:393-398.
3. Burlew B.S., Weber K.T. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 2002, 27:92-98.
4. Martos R., Baugh J., Ledwidge M., O'Loughlin C., Conlon C., Patle A., Donnelly S.C., McDonald K. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007, 115:888-895.
5. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
6. van Herpen N.A., Schrauwen-Hinderling V.B. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008, 94:231-241.
7. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007, 8:253-261.
8. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., Di Mario U., Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88:5163-5168.
9. Ahn S.G., Lim H.S., Joe D.Y., Kang S.J., Choi B.J., Choi S.Y., Yoon M.H., Hwang G.S., Tahk S.J., Shin J.H. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008, 94:e7.
10. Konishi M., Sugiyama S., Sugamura K., Nozaki T., Matsubara J., Akiyama E., Utsunomiya D., Matsuzawa Y., Yamashita Y., Kimura K., Umemura S., Ogawa H. Accumulation of pericardial fat correlates with left ventricular diastolic dysfunction in patients with normal ejection fraction. J Cardiol 2012, 59:344-351.
11. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565-1574.
12. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J., Chamber Quantification Writing Group, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
13. Lester S.J., Ryan E.W., Schiller N.B., Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 1999, 84:829-832.
14. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55:613-618.
15. Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U., Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
16. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543.
17. Marchington J.M., Mattacks C.A., Pond C.M. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989, 94:225-232.
18. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
19. Taguchi R., Takasu J., Itani Y., Yamamoto R., Yokoyama K., Watanabe S., Masuda Y. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001, 157:203-209.
20. Rosito G.A., Massaro J.M., Hoffmann U., Ruberg F.L., Mahabadi A.A., Vasan R.S., O'Donnell C.J., Fox C.S. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008, 117:605-613.
21. Sicari R., Sironi A.M., Petz R., Frassi F., Chubuchny V., De Marchi D., Positano V., Lombardi M., Picano E., Gastaldelli A. Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr 2011, 24:1156-1162.
22. Mookadam F., Goel R., Alharthi M.S., Jiamsripong P., Cha S. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views 2010, 11:103-108.
23. Sade L.E., Eroglu S., Bozbas H., Ozbicer S., Hayran M., Haberal A., Müderrisoĝlu H. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009, 204:580-585.
24. Yilmaz Y., Kurt R., Gurdal A., Alahdab Y.O., Yonal O., Senates E., Polat N., Eren F., Imeryuz N., Oflaz H. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011, 217:125-129.
25. Mahfouz R.A., Dwidar A.E., El Tahlawi M.A. Endothelial-mediated coronary flow reserve and its relation to mitral annular tissue Doppler velocities in offspring of hypertensive parents. Echocardiography 2011, 28:1113-1118.
26. Sasaki O., Hamada M., Hiwada K. Effects of coronary blood flow on left ventricular function in essential hypertensive patients. Hypertens Res 2000, 23:239-245.
27. Kremen J., Dolinkova M., Krajickova J., Blaha J., Anderlova K., Lacinova Z., Haluzikova D., Bosanska L., Vokurka M., Svacina S., Haluzik M. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006, 91:4620-4627.
28. Cheng K.H., Chu C.S., Lee K.T., Lin T.H., Hsieh C.C., Chiu C.C., Voon W.C., Sheu S.H., Lai W.T. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008, 32:268-274.
29. Fain J.N., Sacks H.S., Buehrer B., Bahouth S.W., Garrett E., Wolf R.Y., Carter R.A., Tichansky D.S., Madan A.K. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond) 2008, 32:810-815.
30. Melendez G.C., McLarty J.L., Levick S.P., Du Y., Janicki J.S., Brower G.L. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010, 56:225-231.
31. Kapur N.K. Transforming growth factor-beta: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function. Circ Heart Fail 2011, 4:5-7.
32. Mak G.J., Ledwidge M.T., Watson C.J., Phelan D.M., Dawkins I.R., Murphy N.F., Patle A.K., Baugh J.A., McDonald K.M. Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol 2009, 54:1674-1682.
33. Corradi D., Maestri R., Callegari S., Pastori P., Goldoni M., Luong T.V., Bordi C. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004, 13:313-316.
34. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004, 94:1084-1087.
35. Jalil J.E., Doering C.W., Janicki J.S., Pick R., Shroff S.G., Weber K.T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989, 64:1041-1050.
36. Brilla C.G., Funck R.C., Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000, 102:1388-1393.
37. Schwartzkopff B., Brehm M., Mundhenke M., Strauer B.E. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000, 36:220-225.
38. Abhayaratna W.P., Seward J.B., Appleton C.P., Douglas P.S., Oh J.K., Tajik A.J., Tsang T.S. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006, 47:2357-2363.
39. Leung D.Y., Boyd A., Ng A.A., Chi C., Thomas L. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Am Heart J 2008, 156:1056-1064.
40. Bouzas-Mosquera A., Broullon F.J., Alvarez-Garcia N., Mendez E., Peteiro J., Gandara-Sambade T., Prada O., Mosquera V.X., Castro-Beiras A. Left atrial size and risk for all-cause mortality and ischemic stroke. CMAJ 2011, 183:E657-E664.
41. Katayama T., Fujiwara N., Tsuruya Y. Factors contributing to left atrial enlargement in adults with normal left ventricular systolic function. J Cardiol 2010, 55:196-204.
42. Nelson M.R., Mookadam F., Thota V., Emani U., Al Harthi M., Lester S.J., Cha S., Stepanek J., Hurst R.T. Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?. J Am Soc Echocardiogr 2011, 24:339-345.
43. Nakanishi R., Rajani R., Cheng V.Y., Gransar H., Nakazato R., Shmilovich H., Otaki Y., Hayes S.W., Thomson L.E., Friedman J.D., Slomka P.J., Berman D.S., Dey D. Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis 2011, 218:363-368.